BrachyDOSE
Kaunas
About BrachyDOSE
BrachyDOSE is the game changing cancer treatment quality control tool to empower oncology doctors to provide 100% accurate and error free radiotherapy treatment. Solution solves a problem touching 200 mln patients World Wide and +2000 hospitals in both Europe and the USA. This is a new approach of combining hardware dose measurement tool with deep learning algorithms to provide high accuracy data. It will help to reduce overall treatment costs per patient by 3-5 times, to saves up to 50% of doctors' and medical specialists' time for procedure preparation and will help cancer patient to came back to normal life sooner. BrachyDOSE solution consists of two parts: hardware and software. The radiation dose measurement tool – called sensor (hardware), a scanner to retrieve the data (hardware) and the injury prediction algorithm giving the decision support for a doctor (software). The sensor is in a shape of the flexible tube, it is disposable and at least one must be used during the procedure. One to five sensors could be used for a single procedure, according to the doctor’s prescription and the specific treatment plan.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $802.9K
- Funding stage: Seed
- Last round: Seed (Jul 2025)
- Website: brachydose.net
- Phone: +37061134592
Industries & Categories
Machinery Manufacturing, Mechanical Engineering, Medical, Medical Device, Oncology
Social Profiles
Canonical: https://fsome.com/organization/brachydose-108601 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.